Hepatitis Monthly

Published by: Kowsar

Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan

Arash Alaei 1 , 2 , Kathryn Mishkin 1 , * , Saifuddin Karimov 3 , Dilshod Saidi 3 and Kamiar Alaei 1 , 4
Authors Information
1 Global Institute for Health and Human Rights, University at Albany, State University of New York, Albany, NY, USA
2 Department of Health Policy, Management, and Behavior, University at Albany School of Public Health, State University of New York, Albany, NY, USA
3 Republican AIDS Center, Tajikistan Ministry of Health, Dushanbe, Tajikistan
4 Rockefeller College, University at Albany, State University of New York, Albany, NY, USA
Article information
  • Hepatitis Monthly: March 2018, 18 (3); e64860
  • Published Online: April 28, 2018
  • Article Type: Brief Report
  • Received: December 7, 2017
  • Revised: January 18, 2018
  • Accepted: April 20, 2018
  • DOI: 10.5812/hepatmon.64860

To Cite: Alaei A, Mishkin K, Karimov S, Saidi D, Alaei K. et al. Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan, Hepat Mon. 2018 ;18(3):e64860. doi: 10.5812/hepatmon.64860.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Thorne C, Ferencic N, Malyuta R, Mimica J, Niemiec T. Central Asia: hotspot in the worldwide HIV epidemic. Lancet Infect Dis. 2010;10(7):479-88. doi: 10.1016/S1473-3099(10)70118-3. [PubMed: 20610330].
  • 2. National AIDS Program Data Report. Dushanbe: Tajikistan Ministry of Health; 2017.Tajikistan Ministry of Health.
  • 3. Walsh N, Maher L. HIV and HCV among people who inject drugs in Central Asia. Drug Alcohol Depend. 2013;132 Suppl 1:S37-40. doi: 10.1016/j.drugalcdep.2013.06.030. [PubMed: 23906997].
  • 4. Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016;388(10050):1228-48. doi: 10.1016/S0140-6736(16)30856-X. [PubMed: 27427455].
  • 5. Jolley E, Rhodes T, Platt L, Hope V, Latypov A, Donoghoe M, et al. HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy. BMJ Open. 2012;2(5). doi: 10.1136/bmjopen-2012-001465. [PubMed: 23087014].
  • 6. Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol Infect. 2002;129(3):577-85. [PubMed: 12558341].
  • 7. Mansfeld M, Ristola M, Klinte J, Bultman J, Kastelic A, Rotberga S. HIV programme review in Tajikistan. WHO; 2015.
  • 8. Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, Flom PL, et al. Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend. 2007;89(1):1-12. doi: 10.1016/j.drugalcdep.2006.11.014. [PubMed: 17174481].
  • 9. Strengthening the capacity of the Republican AIDS center to implement HIV program in the Republic of Tajikistan under the president's emergency plan for AIDS relief (PEPFAR). 2015.CDC.
  • 10. Belaunzaran-Zamudio PF, Mosqueda-Gomez JL, Macias-Hernandez A, Sierra-Madero JG, Ahmed S, Beyrer C. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. PLoS One. 2017;12(6). e0179931. doi: 10.1371/journal.pone.0179931. [PubMed: 28654650].
  • 11. Buxton JA, Yu A, Kim PH, Spinelli JJ, Kuo M, Alvarez M, et al. HCV co-infection in HIV positive population in British Columbia, Canada. BMC Public Health. 2010;10:225. doi: 10.1186/1471-2458-10-225. [PubMed: 20429917].
  • 12. Bivigou-Mboumba B, Rouet F, Mouinga-Ondeme A, Deleplancque L, Sica J, Ndjoyi-Mbiguino A, et al. Hepatitis B, C, and E infection among HIV-infected patients in Franceville, Gabon: retrospective cross-sectional study. Med Sante Trop. 2017;27(3):274-80. doi: 10.1684/mst.2017.0698. [PubMed: 28947403].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments